D. Western Therapeutics Institute, Inc.
Notice on Monthly Exercise Status of the 13th Stock Acquisition Rights (with Exercise Price Adjustment Clause)
Publish the monthly exercise status for the 13th stock acquisition rights (with exercise price adjustment clause) issued on July 31, 2025, for July 2026. Granted shares: 76,000 shares; exercised stock acquisition rights: 760 units; exercise ratio: 0.17%; unexercised: 9,098 shares → 8,338 shares decrease. At the end of the previous month, issued shares were 57,483,412 (including 11,387 treasury shares).
Key Figures
- 交付株式数: 76,000 株
- 行使された新株予約権の数: 760 個
- 行使比率: 0.17%
AI要約
月間行使状況の概要
This report conveys the monthly exercise status for the 13th stock acquisition rights with an exercise price adjustment clause issued on July 31, 2025, for July 2026. For the target month, the number of granted shares is 76,000, the number of stock acquisition rights exercised is 760, and the exercise ratio against the issued total is 0.17%, remaining at a low level. Unexercised stock acquisition rights at month-end total 8,338 shares, down from 9,098 shares at the end of the previous month.
Share issuance status and compliance
The number of issued shares is 57,483,412 (including 11,387 treasury shares), and compliance with exercise restrictions is properly managed. The exercise this time was conducted in accordance with specific internal period conditions and is reported to conform to exchange and market rules.
De WESTERN Therapitecs Institute
Company overview · Stock price · Financial data · All IR
